Advertisement

Topics

Intercept's PBC treatment gains EMA conditional approval

05:41 EDT 18 Oct 2016 | SmartBrief

Intercept Pharmaceuticals has received conditional approval from the European Medicines Agency for Ocaliva, or obeticholic ac -More

Original Article: Intercept's PBC treatment gains EMA conditional approval

NEXT ARTICLE

More From BioPortfolio on "Intercept's PBC treatment gains EMA conditional approval"

Quick Search
Advertisement